• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Angiodynamics Inc (NQ: ANGO )

    6.950 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,227
    Open 6.950
    Bid (Size) 6.350 (2)
    Ask (Size) 7.140 (3)
    Prev. Close 6.950
    Today's Range 6.950 - 6.950
    52wk Range 5.260 - 9.770
    Shares Outstanding 38,444,076
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
    Via Benzinga
    Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
    AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company... 
    Via Benzinga

    Performance

    YTD
    -13.45%
    -13.45%
    1 Month
    +23.01%
    +23.01%
    3 Month
    +13.56%
    +13.56%
    6 Month
    +19.01%
    +19.01%
    1 Year
    -22.09%
    -22.09%

    More News

    Read More
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024
    Via InvestorPlace
    AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
    From AngioDynamics, Inc.
    Via Business Wire
    Insiders Buying Zumiez And 3 Other Stocks
    Via Benzinga
    Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
    Via Benzinga
    Exposures Product Safety
    ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
    From AngioDynamics, Inc.
    Via Business Wire
    Earnings Scheduled For April 4, 2024
    Via Benzinga
    AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
    From AngioDynamics, Inc.
    Via Business Wire
    Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
    Via InvestorPlace
    AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
    From AngioDynamics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.